相关实验视频
Updated: Jun 20, 2025

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
17.5K
药物动力学,动力学和遗传学模型建议的早产婴儿的芬太尼尔剂量
Maddlie Bardol1,2, Elisabeth Norman3,4, Hugo Lagercrantz5
1Institute of Child Health, University College London, London, UK. Maddlie.bardol@pharmetheus.com.
Pediatric research
|July 18, 2024
概括
对于早产婴儿的芬太尼尔剂量需要考虑成熟和遗传因素. 对于疼痛的手术,如输管术,建议使用2μg/kg的静脉注射剂量,因为特定的基因变异会影响芬太尼清除.
科学领域:
- 新生儿药理学 新生儿药理学
- 药物遗传学 药物遗传学
- 疼痛管理 疼痛管理
背景情况:
- 芬太尼经常用于早产婴儿的手术疼痛.
- 这种人群的最佳芬太尼度仍未确定.
研究的目的:
- 为了研究芬太尼在早产婴儿中的药理动力学 (PK),药理动力学 (PD) 和药理遗传学 (PG).
- 在这个易受伤害的群体中,为痛苦的手术建立适当的芬太尼剂量.
主要方法:
- 一组25名早产婴儿 (妊娠年龄为23.3-34.1周) 在手术前接受了芬太尼 (0.5或2μg/kg).
- 采用PK/PD建模,结合疼痛评分 (EDIN) 和药物代谢酶,转运体和受体中的遗传多态性.
- 分析了重量和成熟度等共变量对芬太尼清除的影响.
主要成果:
- 一个两部分的PK模型有效地描述了芬太尼度,重量和成熟度影响了清除.
- 在ABCC1和ABCC3载体中的遗传变异显著影响了芬太尼的消除,占个人间清除差异的15%.
- 一个PK/PD模型将芬太尼度与EDIN疼痛评分联系起来.
结论:
- 建议在早产婴儿的明显疼痛的手术,如输内管,静脉注射芬太尼剂量为2μg/kg.
- 个性化芬太尼止痛应纳入婴儿成熟和影响药物消除的阿片类载体 (ABCC1,ABCC3) 的遗传变异.
相关概念视频
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Pharmacokinetic Models: Comparison and Selection Criterion
66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66
Pharmacokinetic Models: Overview
643
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
643
Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
Nonlinear Pharmacokinetics: Overview
337
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
337
One-Compartment Open Model for IV Bolus Administration: General Considerations
182
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
182

